Gilead Sciences
GILD
#97
Rank
C$276.63 B
Marketcap
C$223.10
Share price
0.08%
Change (1 day)
32.36%
Change (1 year)

EPS for Gilead Sciences (GILD)

EPS in 2026 (TTM): C-$3.90

According to Gilead Sciences's latest financial reports the company's current EPS (TTM) is C-$3.64. In 2025 the company made an earnings per share (EPS) of C$9.60 an increase over its 2024 EPS that were of C$0.53.

EPS history for Gilead Sciences from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$3.90-140.64%
2025C$9.601702.63%
2024C$0.53-91.65%
2023C$6.3823.98%
2022C$5.14-25.86%
2021C$6.944850%
2020C$0.14-97.64%
2019C$5.940.9%
2018C$5.8918.71%
2017C$4.96-64.88%
2016C$14.13-18.45%
2015C$17.3255.28%
2014C$11.16296.02%
2013C$2.8217.89%
2012C$2.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$12.24-435.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$1.07-129.23%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
C$5.00-237.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$41.88-1,249.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$22.73-723.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
C$7.96-318.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
C$7.58-308.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
C$24.29-766.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$1.77-148.67%๐Ÿ‡บ๐Ÿ‡ธ USA